A phase I study of E7080 in patients (pts) with advanced malignancies

被引：0
|
作者：
Glen, H.
Boss, D. R.
Morrison, R.
Roelvink, M.
Wanders, J.
Mazur, A.
Gupta, A.
Das, A.
Evans, T. R.
Schellens, J. H.
机构：
[1] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland
[2] Nederlands Kanker Inst, Amsterdam, Neth Antilles
[3] Beatson W Scotland Canc Ctr, Glasgow, Lanark, Scotland
[4] Eisai Med Res, London, England
[5] Univ Glasgow, Glasgow, Lanark, Scotland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3526
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase I dose finding study of E7080 in patients (pts) with advanced malignancies
    Glen, H.
    Boss, D.
    Evans, T. R.
    Roelvink, M.
    Saro, J. M.
    Bezodis, P.
    Copalu, W.
    Das, A.
    Crosswell, G.
    Schellens, J. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours
    Boss, D. S.
    Glen, H.
    Beijnen, J. H.
    Keesen, M.
    Morrison, R.
    Tait, B.
    Copalu, W.
    Mazur, A.
    Wanders, J.
    O'Brien, J. P.
    Schellens, J. H. M.
    Evans, T. R. J.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 106 (10) : 1598 - 1604
  • [3] Phase I dose escalation study and biomarker analysis of E7080 in patients with advanced solid tumors
    Yamada, K.
    Hirata, T.
    Fujiwara, Y.
    Nokihara, H.
    Yamamoto, N.
    Yamada, Y.
    Koizumi, F.
    Nishio, K.
    Koyama, N.
    Tamura, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Phase I/II study of lenvatinib (E7080), a multitargeted tyrosine kinase inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC): Phase I results
    Mitsunaga, Shuichi
    Ikeda, Masafumi
    Ueno, Hideki
    Nakachi, Kohei
    Morizane, Chigusa
    Kondo, Shunsuke
    Shimizu, Satoshi
    Kojima, Yasushi
    Suzuki, Takuya
    Tamai, Toshiyuki
    O'Brien, James P.
    Okusaka, Takuji
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [5] A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours
    D S Boss
    H Glen
    J H Beijnen
    M Keesen
    R Morrison
    B Tait
    W Copalu
    A Mazur
    J Wanders
    J P O'Brien
    J H M Schellens
    T R J Evans
    [J]. British Journal of Cancer, 2012, 106 : 1598 - 1604
  • [6] Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Tumors
    Yamada, Kazuhiko
    Yamamoto, Noboru
    Yamada, Yasuhide
    Nokihara, Hiroshi
    Fujiwara, Yutaka
    Hirata, Taizo
    Koizumi, Fumiaki
    Nishio, Kazuto
    Koyama, Noriyuki
    Tamura, Tomohide
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (08) : 2528 - 2537
  • [7] Phase I dose-escalation study of E7080, a multikinase inhibitor, in patients with advanced solid tumors
    Nemunaitis, J. J.
    Senzer, N. N.
    Kurzrock, R.
    Ng, C. S.
    Das, A.
    Atienza, R. S.
    Zang, E. A.
    Jansen, M.
    Ashworth, S.
    Hong, D. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] A PHASE I AND DOSE-FINDING STUDY OF LENVATINIB (E7080) IN JAPANESE PATIENTS WITH ADVANCED SOLID TUMORS
    Yamamoto, N.
    Nokihara, H.
    Yamada, Y.
    Honda, K.
    Wakui, H.
    Sasaki, T.
    Yusa, W.
    Tamura, T.
    [J]. ANNALS OF ONCOLOGY, 2013, 24
  • [9] PHASE I/II TRIAL OF LENVATINIB (E7080), A MULTI-TARGETED TYROSINE KINASE INHIBITOR, IN PATIENTS (PTS) WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
    Ikeda, K.
    Kumada, H.
    Kudo, M.
    Kawazoe, S.
    Osaki, Y.
    Ikeda, M.
    Okusaka, T.
    Suzuki, T.
    O'Brien, J. P.
    Okita, K.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 244 - 244
  • [10] Subgroup analyses of a phase 1/2 study of lenvatinib (E7080), a multitargeted tyrosine kinase inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Ikeda, Masafumi
    Ikeda, Kenji
    Kudo, Masatoshi
    Osaki, Yukio
    Okusaka, Takuji
    Tamai, Toshiyuki
    Suzuki, Takuya
    Hisai, Takashi
    Miyagishi, Hideaki
    Okita, Kiwamu
    Kumada, Hiromitsu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
12345